𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune cytolysis of murine tumor cells mediated by xenogeneic “Immune” RNA

✍ Scribed by David H. Kern; Yosef H. Pilch


Publisher
John Wiley and Sons
Year
1974
Tongue
French
Weight
722 KB
Volume
13
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Using a quantitative assay for lymphocyte‐mediated cytotoxicity, it was shown that normal, non‐immune C3Hf/HeCr mouse spleen cells were converted to effector cells specifically cytotoxic to chemically induced C3H tumor cells by incubation in vitro with “immune” RNA extracted from the lymphoid organs of specifically immunized guineapigs. This response was specific for the tumor used to immunize the RNA donor. Cytotoxicity indices (CIs) at 0.30 to 0.54 were consistently obtained. Spleen cells incubated with RNA from guinea‐pigs immunized with a different tumor, or with normal C3H tissue, failed to lyse the target cells. These immune responses were abrogated when the “immune” RNA was treated with RNase prior to incubation with the spleen cells. However, pre‐treatment with DNase or pronase did not alter the activity of the “immune” RNA. “Immune” RNA to a second chemically induced C3H tumor mediated a cytotoxic response to that tumor (CI=0.45), but not to the first tumor. This clearly demonstrates that xenogeneic “immune” RNA mediates tumor‐specific immune cytolysis, in vitro.


📜 SIMILAR VOLUMES


Cell-mediated immune reaction against tu
✍ J. C. Leclerc; E. Gomard; F. Plata; J. P. Levy 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 French ⚖ 514 KB

## Abstract The nature of the effector cells detected by the chromium release test (CRT) has been studied in BALB/c and C57Bl/6 mice bearing murine sarcoma virus (MSV)‐induced tumors. Anti‐θ‐C3H immune sera completely inhibited the cytotoxic activity of lymphoid cells in the presence of complement;

Tumor immunity to murine plasma cell tum
✍ B. T. Rouse; M. Röllinghoff; N. L. Warner 📂 Article 📅 1973 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

## Abstract Spleen cells, thoracic duct lymphocytes and adherent peritoneal exudate cells from mice immunized to syngeneic plasma cell tumors were capable of transferring specific protective immunity to these tumors. Pre‐treatment of these cells with anti‐Θ serum or anti‐lymphocyte serum, but not w

Tumor immunity to murine plasma-cell tum
✍ Janis V. Giorgi; Noel L. Warner 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 686 KB

## Abstract Previous studies have clearly established that murine plasmacytomas suppress B‐cell responses, but no effects on T‐cell responses have been noted by most investigators. However, in our investigation of the tumor‐associated antigens of plasmacytomas, we have found that immunosuppression

Immune rejection mechanisms in murine le
✍ Richard P. Ciavarra; Geronimo Terres 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 776 KB

Studies were undertaken to investigate the relationship between cell-mediated and humoral immune responses in the rejection of LIZIOIMTX-Rev (LR) leukemia cells in CDZF, mice. The anti-LRantibudy (humoral) response was defined by both ik cytotoxic antibody titer and isotype composition, assessed by

Cell-mediated immunity against particula
✍ M. L. Padarathsing; J. H. Dean; J. L. McCoy; D. D. Lewis; J. W. Northing; T. Nat 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

## Abstract Cell‐mediated immunity (CMI), as detected by the agarose microdroplet macrophage migration inhibition (MMI) assay, was investigated using peritoneal exudate cells (PEC) of BALB/c mice and several crude membrane (CM) and solubilized preparations of murine plasmacytomas. The MMI assay was